Originally published October 2019. Updated June 2026.
Bayer — the German pharmaceutical and life-sciences giant — pulled its marketing in-house. It saved tens of millions. It redirected the dollars into digital. The cost story is the one the trade press ran with. The control story is the one that matters now.
What Bayer Actually Did
Bayer spent two years moving its digital media buying in-house, replacing work previously routed through agency contracts. The move was structural, not tactical — Bayer didn't fire its agencies and start over. It built an internal capability, then renegotiated the agency relationships around it. Cost savings were the headline. Speed and control were the point.
The Real Argument for In-House
Full creative control. Faster response to issues. Direct ownership of the data — first-party signals that no agency stack can fully replicate. For a regulated company like Bayer, the data point is especially sharp: pharma marketing lives or dies on compliance, and compliance lives or dies on speed.
The cost argument is real. The control argument is bigger.
What Changed Since 2019 — The AI Layer
In 2019 the in-house question was about media buying and creative production. In 2026 it's about something else entirely: who owns the brand's answer inside ChatGPT, Claude, Gemini, Perplexity, and Google AI Overviews.
More than a third of consumers now start product research with AI, not Google. For a Bayer aspirin or a Bayer Claritin or a Bayer animal-health product, the new shelf is the chatbox. The new first impression is the citation. And citation share is not bought — it's built. With structured content, entity authority, primary-source publishing, and a measurement layer that tracks share of answer across every engine that matters.
Why Bayer's Move Is a Tell
Companies that bring marketing in-house are signaling something simple: the function is too strategic to outsource end-to-end. That logic compounds in the AI era. The brands that win citation share are the ones with the cleanest source signals, the most consistent entity data, and the fastest response to a fact pattern that shifts in days, not quarters.
Agencies that survive this shift won't be the ones cheaper than in-house. They'll be the ones who build the AI visibility layer the in-house team can't build alone — research, measurement, GEO, and citation infrastructure across the engines that have replaced search as the first stop in buyer research.
Bayer's bet looks like a media story. It's an authority story. And authority now lives inside the answer.
Ronn Torossian is shaping AI — and the answers inside the chatbox.
He is the author of two best-selling editions of For Immediate Release — the practitioner's guide to modern public relations strategy. He has been an industry leader for decades. Now he's building the AI Communications era.
Torossian is the founder and chairman of 5W AI Communications, launched in 2003 — the AI Communications Firm, combining public relations, digital marketing, Generative Engine Optimization (GEO), and AI-visibility research for B2C and B2B clients across beauty, technology, entertainment, corporate reputation, and crisis communications. An Inc. 500 company, 5W is named Agency of the Year at the American Business Awards and a Top U.S. PR Agency by O'Dwyer's.
